Ion-Current-Based Temporal Proteomic Profiling of Influenza-A-Virus-Infected Mouse Lungs Revealed Underlying Mechanisms of Altered Integrity of the Lung Microvascular Barrier

Journal of Proteome Research

Volumn 15, Issue 2, 2016, Pages 540-553

  Shen, Shichen ^a,b   Li, Jun ^a   Hilchey, Shannon ^d   Shen, Xiaomeng ^a,b   Tu, Chengjian ^a   Qiu, Xing ^c   Ng, Andrew ^b   Ghaemmaghami, Sina ^c   Wu, Hulin ^e   Zand, Martin S ^d   Qu, Jun ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

bottom up proteomics; host factors; influenza; ion current based quantification; microvascular barrier

Indexed keywords

CADHERIN; CATENIN; CLAUDIN; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN ZO1; PROTEOME; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE DISMUTASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL JUNCTION; DOWN REGULATION; INFLUENZA A; ION CURRENT; LUNG; LUNG ALVEOLUS EPITHELIUM; LUNG CAPILLARY; LUNG DISEASE; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; PULMONARY CAPILLARY ALVEOLAR LEAK SYNDROME; REVERSED PHASE LIQUID CHROMATOGRAPHY; UPREGULATION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; INFLUENZA A VIRUS (H3N2); LUNG GAS EXCHANGE; METABOLISM; ORTHOMYXOVIRUS INFECTION; PHYSIOLOGY; PROCEDURES; PROTEOMICS; STATISTICAL MODEL; VASCULARIZATION; VIROLOGY;

ANIMALS; BLOOD-AIR BARRIER; BLOTTING, WESTERN; CHROMATOGRAPHY, REVERSE-PHASE; INFLUENZA A VIRUS, H3N2 SUBTYPE; LINEAR MODELS; LUNG; MALE; MASS SPECTROMETRY; MATRIX METALLOPROTEINASE 9; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; PROTEOME; PROTEOMICS;

EID: 84957628834     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/acs.jproteome.5b00927     Document Type: Article

References (101)

1. Watanabe, T.; Kawaoka, Y. Pathogenesis of the 1918 Pandemic Influenza Virus PLoS Pathog. 2011, 7, e1001218 10.1371/journal.ppat.1001218
2. Hayden, F. G.; de Jong, M. D. Emerging influenza antiviral resistance threats J. Infect. Dis. 2011, 203, 6-10 10.1093/infdis/jiq012
3. Konig, R.; Stertz, S.; Zhou, Y.; Inoue, A.; Hoffmann, H. H.; Bhattacharyya, S.; Alamares, J. G.; Tscherne, D. M.; Ortigoza, M. B.; Liang, Y.; Gao, Q.; Andrews, S. E.; Bandyopadhyay, S.; De Jesus, P.; Tu, B. P.; Pache, L.; Shih, C.; Orth, A.; Bonamy, G.; Miraglia, L.; Ideker, T.; Garcia-Sastre, A.; Young, J. A.; Palese, P.; Shaw, M. L.; Chanda, S. K. Human host factors required for influenza virus replication Nature 2010, 463, 813-7 10.1038/nature08699
4. Carette, J. E.; Guimaraes, C. P.; Varadarajan, M.; Park, A. S.; Wuethrich, I.; Godarova, A.; Kotecki, M.; Cochran, B. H.; Spooner, E.; Ploegh, H. L.; Brummelkamp, T. R. Haploid genetic screens in human cells identify host factors used by pathogens Science 2009, 326, 1231-1235 10.1126/science.1178955
5. Karlas, A.; Machuy, N.; Shin, Y.; Pleissner, K. P.; Artarini, A.; Heuer, D.; Becker, D.; Khalil, H.; Ogilvie, L. A.; Hess, S.; Maurer, A. P.; Muller, E.; Wolff, T.; Rudel, T.; Meyer, T. F. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication Nature 2010, 463, 818-22 10.1038/nature08760
6. Shapira, S. D.; Gat-Viks, I.; Shum, B. O.; Dricot, A.; de Grace, M. M.; Wu, L.; Gupta, P. B.; Hao, T.; Silver, S. J.; Root, D. E.; Hill, D. E.; Regev, A.; Hacohen, N. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection Cell 2009, 139, 1255-67 10.1016/j.cell.2009.12.018
7. Gygi, S. P.; Rochon, Y.; Franza, B. R.; Aebersold, R. Correlation between protein and mRNA abundance in yeast Mol. Cell. Biol. 1999, 19, 1720-30 10.1128/MCB.19.3.1720
8. Schwanhausser, B.; Busse, D.; Li, N.; Dittmar, G.; Schuchhardt, J.; Wolf, J.; Chen, W.; Selbach, M. Global quantification of mammalian gene expression control Nature 2011, 473, 337-42 10.1038/nature10098
9. Lilley, K. S.; Razzaq, A.; Dupree, P. Two-dimensional gel electrophoresis: recent advances in sample preparation, detection and quantitation Curr. Opin. Chem. Biol. 2002, 6, 46-50 10.1016/S1367-5931(01)00275-7
10. Ong, S. E.; Blagoev, B.; Kratchmarova, I.; Kristensen, D. B.; Steen, H.; Pandey, A.; Mann, M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics Mol. Cell. Proteomics 2002, 1, 376-86 10.1074/mcp.M200025-MCP200
11. Emmott, E.; Wise, H.; Loucaides, E. M.; Matthews, D. A.; Digard, P.; Hiscox, J. A. Quantitative proteomics using SILAC coupled to LC-MS/MS reveals changes in the nucleolar proteome in influenza A virus-infected cells J. Proteome Res. 2010, 9, 5335-45 10.1021/pr100593g
12. Liu, N.; Song, W.; Wang, P.; Lee, K.; Chan, W.; Chen, H.; Cai, Z. Proteomics analysis of differential expression of cellular proteins in response to avian H9N2 virus infection in human cells Proteomics 2008, 8, 1851-8 10.1002/pmic.200700757
13. Teran, L. M.; Ruggeberg, S.; Santiago, J.; Fuentes-Arenas, F.; Hernandez, J. L.; Montes-Vizuet, A. R.; Xinping, L.; Franz, T. Immune response to seasonal influenza A virus infection: a proteomic approach Arch. Med. Res. 2012, 43, 464-9 10.1016/j.arcmed.2012.08.008
14. Vester, D.; Rapp, E.; Gade, D.; Genzel, Y.; Reichl, U. Quantitative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell lines Proteomics 2009, 9, 3316-27 10.1002/pmic.200800893
15. Tawaratsumida, K.; Phan, V.; Hrincius, E. R.; High, A. A.; Webby, R.; Redecke, V.; Hacker, H. Quantitative proteomic analysis of the influenza A virus nonstructural proteins NS1 and NS2 during natural cell infection identifies PACT as an NS1 target protein and antiviral host factor J. Virol. 2014, 88, 9038-48 10.1128/JVI.00830-14
16. Zhao, H.; Yang, J.; Li, K.; Ding, X.; Lin, R.; Ma, Y.; Liu, J.; Zhong, Z.; Qian, X.; Bo, X.; Zhou, Z.; Wang, S. Proteomic analysis at the subcellular level for host targets against influenza A virus (H1N1) Antiviral Res. 2013, 100, 673-87 10.1016/j.antiviral.2013.10.005
17. Shen, X.; Hu, Q.; Li, J.; Wang, J.; Qu, J. An Experimental Null method to guide the development of technical procedures and to control false positive discovery in quantitative proteomics J. Proteome Res. 2015, 14, 4147 10.1021/acs.jproteome.5b00200
18. Megger, D. A.; Bracht, T.; Meyer, H. E.; Sitek, B. Label-free quantification in clinical proteomics Biochim. Biophys. Acta, Proteins Proteomics 2013, 1834, 1581-90 10.1016/j.bbapap.2013.04.001
19. Geiger, T.; Cox, J.; Ostasiewicz, P.; Wisniewski, J. R.; Mann, M. Super-SILAC mix for quantitative proteomics of human tumor tissue Nat. Methods 2010, 7, 383-385 10.1038/nmeth.1446
20. Viner, R.; Bomgarden, R.; Blank, M.; Rogers, J. In Increasing the Multiplexing of Protein Quantitation from 6-to 10-Plex with Reporter Ion Isotopologues, 61st ASMS Conference on Mass Spectrometry and Allied Topics. Minneapolis Convention Center, MN, USA, 2013.
21. Wiese, S.; Reidegeld, K. A.; Meyer, H. E.; Warscheid, B. Protein labeling by iTRAQ: a new tool for quantitative mass spectrometry in proteome research Proteomics 2007, 7, 340-50 10.1002/pmic.200600422
22. Neilson, K. A.; Ali, N. A.; Muralidharan, S.; Mirzaei, M.; Mariani, M.; Assadourian, G.; Lee, A.; van Sluyter, S. C.; Haynes, P. A. Less label, more free: approaches in label-free quantitative mass spectrometry Proteomics 2011, 11, 535-53 10.1002/pmic.201000553
23. Calvo, S. E.; Mootha, V. K. The mitochondrial proteome and human disease Annu. Rev. Genomics Hum. Genet. 2010, 11, 25-44 10.1146/annurev-genom-082509-141720
24. Bildl, W.; Haupt, A.; Muller, C. S.; Biniossek, M. L.; Thumfart, J. O.; Huber, B.; Fakler, B.; Schulte, U. Extending the dynamic range of label-free mass spectrometric quantification of affinity purifications Mol. Cell. Proteomics 2012, 11, M111.007955 10.1074/mcp.M111.007955
25. Schindler, J.; Nothwang, H. G. Aqueous polymer two-phase systems: effective tools for plasma membrane proteomics Proteomics 2006, 6, 5409-17 10.1002/pmic.200600243
26. Carr, S. A.; Anderson, L. Protein quantitation through targeted mass spectrometry: the way out of biomarker purgatory? Clin. Chem. 2008, 54, 1749-52 10.1373/clinchem.2008.114686
27. Diamandis, E. P. Cancer biomarkers: can we turn recent failures into success? J. Natl. Cancer Inst 2010, 102, 1462-7 10.1093/jnci/djq306
28. Rifai, N.; Gillette, M. A.; Carr, S. A. Protein biomarker discovery and validation: the long and uncertain path to clinical utility Nat. Biotechnol. 2006, 24, 971-83 10.1038/nbt1235
29. Karpievitch, Y. V.; Dabney, A. R.; Smith, R. D. Normalization and missing value imputation for label-free LC-MS analysis BMC Bioinf. 2012, 13, S5-S5 10.1186/1471-2105-13-S16-S5
30. An, B.; Zhang, M.; Johnson, R. W.; Qu, J. Surfactant-Aided Precipitation/on-Pellet-Digestion (SOD) Procedure Provides Robust and Rapid Sample Preparation for Reproducible, Accurate and Sensitive LC/MS Quantification of Therapeutic Protein in Plasma and Tissues Anal. Chem. 2015, 87, 4023-9 10.1021/acs.analchem.5b00350
31. Duan, X.; Young, R.; Straubinger, R. M.; Page, B.; Cao, J.; Wang, H.; Yu, H.; Canty, J. M.; Qu, J. A straightforward and highly efficient precipitation/on-pellet digestion procedure coupled with a long gradient nano-LC separation and Orbitrap mass spectrometry for label-free expression profiling of the swine heart mitochondrial proteome J. Proteome Res. 2009, 8, 2838-50 10.1021/pr900001t
32. Tu, C.; Li, J.; Sheng, Q.; Zhang, M.; Qu, J. Systematic assessment of survey scan and MS2-based abundance strategies for label-free quantitative proteomics using high-resolution MS data J. Proteome Res. 2014, 13, 2069-79 10.1021/pr401206m
33. Searle, B. C. Scaffold: a bioinformatic tool for validating MS/MS-based proteomic studies Proteomics 2010, 10, 1265-9 10.1002/pmic.200900437
34. Elias, J. E.; Haas, W.; Faherty, B. K.; Gygi, S. P. Comparative evaluation of mass spectrometry platforms used in large-scale proteomics investigations Nat. Methods 2005, 2, 667-75 10.1038/nmeth785
35. Lopez, M. F.; Kuppusamy, R.; Sarracino, D. A.; Prakash, A.; Athanas, M.; Krastins, B.; Rezai, T.; Sutton, J. N.; Peterman, S.; Nicolaides, K. Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum J. Proteome Res. 2011, 10, 133-42 10.1021/pr100153j
36. Diz, A. P.; Carvajal-Rodriguez, A.; Skibinski, D. O. Multiple hypothesis testing in proteomics: a strategy for experimental work Mol. Cell. Proteomics 2011, 10, M110.004374 10.1074/mcp.M110.004374
37. Nouri-Nigjeh, E.; Sukumaran, S.; Tu, C.; Li, J.; Shen, X.; Duan, X.; DuBois, D. C.; Almon, R. R.; Jusko, W. J.; Qu, J. Highly multiplexed and reproducible ion-current-based strategy for large-scale quantitative proteomics and the application to protein expression dynamics induced by methylprednisolone in 60 rats Anal. Chem. 2014, 86, 8149-57 10.1021/ac501380s
38. Tu, C.; Mammen, M. J.; Li, J.; Shen, X.; Jiang, X.; Hu, Q.; Wang, J.; Sethi, S.; Qu, J. Large-scale, ion-current-based proteomics investigation of bronchoalveolar lavage fluid in chronic obstructive pulmonary disease patients J. Proteome Res. 2014, 13, 627-39 10.1021/pr4007602
39. Cox, J.; Hein, M. Y.; Luber, C. A.; Paron, I.; Nagaraj, N.; Mann, M. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ Mol. Cell. Proteomics 2014, 13, 2513-26 10.1074/mcp.M113.031591
40. Huang, D. W.; Sherman, B. T.; Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat. Protoc. 2008, 4, 44-57 10.1038/nprot.2008.211
41. Krogh, A.; Larsson, B.; von Heijne, G.; Sonnhammer, E. L. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes J. Mol. Biol. 2001, 305, 567-80 10.1006/jmbi.2000.4315
42. Sonnhammer, E. L.; von Heijne, G.; Krogh, A. A hidden Markov model for predicting transmembrane helices in protein sequences Proc.-Int. Conf. Intell. Syst. Mol. Biol. 1998, 6, 175-82
43. Henn, A. D.; Wu, S.; Qiu, X.; Ruda, M.; Stover, M.; Yang, H.; Liu, Z.; Welle, S. L.; Holden-Wiltse, J.; Wu, H.; Zand, M. S. High-Resolution Temporal Response Patterns to Influenza Vaccine Reveal a Distinct Human Plasma Cell Gene Signature Sci. Rep. 2013, 3, 2327 10.1038/srep02327
44. Pommerenke, C.; Wilk, E.; Srivastava, B.; Schulze, A.; Novoselova, N.; Geffers, R.; Schughart, K. Global Transcriptome Analysis in Influenza-Infected Mouse Lungs Reveals the Kinetics of Innate and Adaptive Host Immune Responses PLoS One 2012, 7, e41169 10.1371/journal.pone.0041169
45. Miao, H.; Hollenbaugh, J. A.; Zand, M. S.; Holden-Wiltse, J.; Mosmann, T. R.; Perelson, A. S.; Wu, H.; Topham, D. J. Quantifying the early immune response and adaptive immune response kinetics in mice infected with influenza A virus J. Virol 2010, 84, 6687-98 10.1128/JVI.00266-10
46. Miao, H.; Sangster, M. Y.; Livingstone, A. M.; Hilchey, S. P.; Zhang, L.; Topham, D. J.; Mosmann, T. R.; Holden-Wiltse, J.; Perelson, A. S.; Wu, H.; Zand, M. S. Modeling the dynamics and migratory pathways of virus-specific antibody-secreting cell populations in primary influenza infection PLoS One 2014, 9, e104781 10.1371/journal.pone.0104781
47. Wu, H.; Kumar, A.; Miao, H.; Holden-Wiltse, J.; Mosmann, T. R.; Livingstone, A. M.; Belz, G. T.; Perelson, A. S.; Zand, M. S.; Topham, D. J. Modeling of influenza-specific CD8+ T cells during the primary response indicates that the spleen is a major source of effectors J. Immunol. 2011, 187, 4474-82 10.4049/jimmunol.1101443
48. Gilmore, J. M.; Washburn, M. P. Advances in shotgun proteomics and the analysis of membrane proteomes J. Proteomics 2010, 73, 2078-91 10.1016/j.jprot.2010.08.005
49. Qu, J.; Young, R.; Page, B. J.; Shen, X.; Tata, N.; Li, J.; Duan, X.; Fallavollita, J. A.; Canty, J. M., Jr. Reproducible Ion-Current-Based Approach for 24-Plex Comparison of the Tissue Proteomes of Hibernating versus Normal Myocardium in Swine Models J. Proteome Res. 2014, 13, 2571 10.1021/pr5000472
50. Tu, C.; Li, J.; Jiang, X.; Sheflin, L. G.; Pfeffer, B. A.; Behringer, M.; Fliesler, S. J.; Qu, J. Ion-current-based proteomic profiling of the retina in a rat model of Smith-Lemli-Opitz syndrome Mol. Cell. Proteomics 2013, 12, 3583-98 10.1074/mcp.M113.027847
51. Whitelegge, J. P. Integral membrane proteins and bilayer proteomics Anal. Chem. 2013, 85, 2558-68 10.1021/ac303064a
52. Wu, C. C.; Yates, J. R., 3rd The application of mass spectrometry to membrane proteomics Nat. Biotechnol. 2003, 21, 262-7 10.1038/nbt0303-262
53. Tu, C.; Sheng, Q.; Li, J.; Shen, X.; Zhang, M.; Shyr, Y.; Qu, J. ICan: An Optimized Ion-Current-Based Quantification Procedure with Enhanced Quantitative Accuracy and Sensitivity in Biomarker Discovery J. Proteome Res. 2014, 13, 5888-5897 10.1021/pr5008224
54. Dejana, E.; Orsenigo, F.; Lampugnani, M. G. The role of adherens junctions and VE-cadherin in the control of vascular permeability J. Cell Sci. 2008, 121, 2115-22 10.1242/jcs.017897
55. Lai-Cheong, J. E.; Arita, K.; McGrath, J. A. Genetic diseases of junctions J. Invest. Dermatol. 2007, 127, 2713-25 10.1038/sj.jid.5700727
56. Soini, Y. Claudins in lung diseases Respir Res. 2011, 12, 70 10.1186/1465-9921-12-70
57. Hu, J.; Van den Steen, P. E.; Sang, Q. X.; Opdenakker, G. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases Nat. Rev. Drug Discovery 2007, 6, 480-98 10.1038/nrd2308
58. Navaratna, D.; McGuire, P. G.; Menicucci, G.; Das, A. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes Diabetes 2007, 56, 2380-7 10.2337/db06-1694
59. Vermeer, P. D.; Denker, J.; Estin, M.; Moninger, T. O.; Keshavjee, S.; Karp, P.; Kline, J. N.; Zabner, J. MMP9 modulates tight junction integrity and cell viability in human airway epithelia Am. J. Physiol Lung Cell Mol. Physiol 2009, 296, L751-62 10.1152/ajplung.90578.2008
60. Leng, X.; Ding, T.; Lin, H.; Wang, Y.; Hu, L.; Hu, J.; Feig, B.; Zhang, W.; Pusztai, L.; Symmans, W. F.; Wu, Y.; Arlinghaus, R. B. Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis Cancer Res. 2009, 69, 8579-84 10.1158/0008-5472.CAN-09-1934
61. Yeo, S. J.; Kim, S. J.; Kim, J. H.; Lee, H. J.; Kook, Y. H. Influenza A virus infection modulates the expression of type IV collagenase in epithelial cells Arch. Virol. 1999, 144, 1361-70 10.1007/s007050050592
62. Lee, Y. H.; Lai, C. L.; Hsieh, S. H.; Shieh, C. C.; Huang, L. M.; Wu-Hsieh, B. A. Influenza A virus induction of oxidative stress and MMP-9 is associated with severe lung pathology in a mouse model Virus Res. 2013, 178, 411-22 10.1016/j.virusres.2013.09.011
63. Chakrabarti, S.; Zee, J. M.; Patel, K. D. Regulation of matrix metalloproteinase-9 (MMP-9) in TNF-stimulated neutrophils: novel pathways for tertiary granule release J. Leukocyte Biol. 2005, 79, 214-22 10.1189/jlb.0605353
64. Lee, S. J.; Park, S. S.; Lee, U. S.; Kim, W. J.; Moon, S. K. Signaling pathway for TNF-alpha-induced MMP-9 expression: mediation through p38 MAP kinase, and inhibition by anti-cancer molecule magnolol in human urinary bladder cancer 5637 cells Int. Immunopharmacol. 2008, 8, 1821-6 10.1016/j.intimp.2008.08.018
65. Lee, S. O.; Jeong, Y. J.; Yu, M. H.; Lee, J. W.; Hwangbo, M. H.; Kim, C. H.; Lee, I. S. Wogonin suppresses TNF-alpha-induced MMP-9 expression by blocking the NF-kappaB activation via MAPK signaling pathways in human aortic smooth muscle cells Biochem. Biophys. Res. Commun. 2006, 351, 118-25 10.1016/j.bbrc.2006.10.006
66. Mizumura, K.; Hashimoto, S.; Maruoka, S.; Gon, Y.; Kitamura, N.; Matsumoto, K.; Hayashi, S.; Shimizu, K.; Horie, T. Role of mitogen-activated protein kinases in influenza virus induction of prostaglandin E2 from arachidonic acid in bronchial epithelial cells Clin. Exp. Allergy 2003, 33, 1244-51 10.1046/j.1365-2222.2003.01750.x
67. O'Kane, C. M.; Elkington, P. T.; Jones, M. D.; Caviedes, L.; Tovar, M.; Gilman, R. H.; Stamp, G.; Friedland, J. S. STAT3, p38 MAPK, and NF-kappaB drive unopposed monocyte-dependent fibroblast MMP-1 secretion in tuberculosis Am. J. Respir. Cell Mol. Biol. 2010, 43, 465-74 10.1165/rcmb.2009-0211OC
68. Nguyen, J.; Gogusev, J.; Knapnougel, P.; Bauvois, B. Protein tyrosine kinase and p38 MAP kinase pathways are involved in stimulation of matrix metalloproteinase-9 by TNF-alpha in human monocytes Immunol. Lett. 2006, 106, 34-41 10.1016/j.imlet.2006.04.003
69. Peng, X. Q.; Damarla, M.; Skirball, J.; Nonas, S.; Wang, X. Y.; Han, E. J.; Hasan, E. J.; Cao, X.; Boueiz, A.; Damico, R.; Tuder, R. M.; Sciuto, A. M.; Anderson, D. R.; Garcia, J. G.; Kass, D. A.; Hassoun, P. M.; Zhang, J. T. Protective role of PI3-kinase/Akt/eNOS signaling in mechanical stress through inhibition of p38 mitogen-activated protein kinase in mouse lung Acta Pharmacol. Sin. 2010, 31, 175-83 10.1038/aps.2009.190
70. Kreijtz, J. H.; Fouchier, R. A.; Rimmelzwaan, G. F. Immune responses to influenza virus infection Virus Res. 2011, 162, 19-30 10.1016/j.virusres.2011.09.022
71. Schoggins, J. W.; Rice, C. M. Interferon-stimulated genes and their antiviral effector functions Curr. Opin. Virol. 2011, 1, 519-25 10.1016/j.coviro.2011.10.008
72. Schneider, W. M.; Chevillotte, M. D.; Rice, C. M. Interferon-stimulated genes: a complex web of host defenses Annu. Rev. Immunol. 2014, 32, 513-45 10.1146/annurev-immunol-032713-120231
73. Liu, S. Y.; Sanchez, D. J.; Aliyari, R.; Lu, S.; Cheng, G. Systematic identification of type I and type II interferon-induced antiviral factors Proc. Natl. Acad. Sci. U. S. A. 2012, 109, 4239-44 10.1073/pnas.1114981109
74. Schoggins, J. W.; Wilson, S. J.; Panis, M.; Murphy, M. Y.; Jones, C. T.; Bieniasz, P.; Rice, C. M. A diverse range of gene products are effectors of the type I interferon antiviral response Nature 2011, 472, 481-5 10.1038/nature09907
75. Borden, E. C.; Williams, B. R. Interferon-stimulated genes and their protein products: what and how? J. Interferon Cytokine Res. 2011, 31, 1-4 10.1089/jir.2010.0129
76. Liu, S. Y.; Sanchez, D. J.; Cheng, G. New developments in the induction and antiviral effectors of type I interferon Curr. Opin. Immunol. 2011, 23, 57-64 10.1016/j.coi.2010.11.003
77. Harty, R. N.; Pitha, P. M.; Okumura, A. Antiviral activity of innate immune protein ISG15 J. Innate Immun. 2009, 1, 397-404 10.1159/000226245
78. Lai, C.; Struckhoff, J. J.; Schneider, J.; Martinez-Sobrido, L.; Wolff, T.; Garcia-Sastre, A.; Zhang, D. E.; Lenschow, D. J. Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-adapted and non-mouse-adapted influenza B virus infection J. Virol 2009, 83, 1147-51 10.1128/JVI.00105-08
79. Broquet, A. H.; Hirata, Y.; McAllister, C. S.; Kagnoff, M. F. RIG-I/MDA5/MAVS are required to signal a protective IFN response in rotavirus-infected intestinal epithelium J. Immunol. 2011, 186, 1618-26 10.4049/jimmunol.1002862
80. Kumar, P.; Sweeney, T. R.; Skabkin, M. A.; Skabkina, O. V.; Hellen, C. U.; Pestova, T. V. Inhibition of translation by IFIT family members is determined by their ability to interact selectively with the 5′-terminal regions of cap0-, cap1- and 5′ppp- mRNAs Nucleic Acids Res. 2014, 42, 3228-45 10.1093/nar/gkt1321
81. Diamond, M. S.; Farzan, M. The broad-spectrum antiviral functions of IFIT and IFITM proteins Nat. Rev. Immunol. 2012, 13, 46-57 10.1038/nri3344
82. Desai, T. M.; Marin, M.; Chin, C. R.; Savidis, G.; Brass, A. L.; Melikyan, G. B. IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion PLoS Pathog. 2014, 10, e1004048 10.1371/journal.ppat.1004048
83. Hosakote, Y. M.; Jantzi, P. D.; Esham, D. L.; Spratt, H.; Kurosky, A.; Casola, A.; Garofalo, R. P. Viral-mediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis Am. J. Respir. Crit. Care Med. 2011, 183, 1550-60 10.1164/rccm.201010-1755OC
84. Hosakote, Y. M.; Liu, T.; Castro, S. M.; Garofalo, R. P.; Casola, A. Respiratory syncytial virus induces oxidative stress by modulating antioxidant enzymes Am. J. Respir. Cell Mol. Biol. 2009, 41, 348-57 10.1165/rcmb.2008-0330OC
85. MacNee, W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease Proc. Am. Thorac. Soc. 2005, 2, 50-60 10.1513/pats.200411-056SF
86. Yamada, Y.; Limmon, G. V.; Zheng, D.; Li, N.; Li, L.; Yin, L.; Chow, V. T. K.; Chen, J.; Engelward, B. P. Major Shifts in the Spatio-Temporal Distribution of Lung Antioxidant Enzymes during Influenza Pneumonia PLoS One 2012, 7, e31494 10.1371/journal.pone.0031494
87. Jaitovitch-Groisman, I.; Fotouhi-Ardakani, N.; Schecter, R. L.; Woo, A.; Alaoui-Jamali, M. A.; Batist, G. Modulation of glutathione S-transferase alpha by hepatitis B virus and the chemopreventive drug oltipraz J. Biol. Chem. 2000, 275, 33395-33403 10.1074/jbc.M003754200
88. Hayes, J. D.; Flanagan, J. U.; Jowsey, I. R. Glutathione transferases Annu. Rev. Pharmacol. Toxicol. 2005, 45, 51-88 10.1146/annurev.pharmtox.45.120403.095857
89. Clayton, T. C.; Thompson, M.; Meade, T. W. Eur. Heart J. 2007, 29, 96-103 10.1093/eurheartj/ehm516
90. Madjid, M.; Miller, C. C.; Zarubaev, V. V.; Marinich, I. G.; Kiselev, O. I.; Lobzin, Y. V.; Filippov, A. E.; Casscells, S. W. Eur. Heart J. 2007, 28, 1205-1210 10.1093/eurheartj/ehm035
91. Warren-Gash, C.; Smeeth, L.; Hayward, A. C. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review Lancet Infect. Dis. 2009, 9, 601-610 10.1016/S1473-3099(09)70233-6
92. Ciszewski, A.; Bilinska, Z. T.; Brydak, L. B.; Kepka, C.; Kruk, M.; Romanowska, M.; Ksiezycka, E.; Przyluski, J.; Piotrowski, W.; Maczynska, R.; Ruzyllo, W. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study Eur. Heart J. 2008, 29, 1350-8 10.1093/eurheartj/ehm581
93. Macintyre, C. R.; Heywood, A. E.; Kovoor, P.; Ridda, I.; Seale, H.; Tan, T.; Gao, Z.; Katelaris, A. L.; Siu, H. W.; Lo, V.; Lindley, R.; Dwyer, D. E. Ischaemic heart disease, influenza and influenza vaccination: a prospective case control study Heart 2013, 99, 1843-8 10.1136/heartjnl-2013-304320
94. Udell, J. A.; Zawi, R.; Bhatt, D. L.; Keshtkar-Jahromi, M.; Gaughran, F.; Phrommintikul, A.; Ciszewski, A.; Vakili, H.; Hoffman, E. B.; Farkouh, M. E.; Cannon, C. P. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis JAMA 2013, 310, 1711-20 10.1001/jama.2013.279206
95. Alwaili, K.; Bailey, D.; Awan, Z.; Bailey, S. D.; Ruel, I.; Hafiane, A.; Krimbou, L.; Laboissiere, S.; Genest, J. The HDL proteome in acute coronary syndromes shifts to an inflammatory profile Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 2012, 1821, 405-15 10.1016/j.bbalip.2011.07.013
96. Van Lenten, B. J.; Wagner, A. C.; Nayak, D. P.; Hama, S.; Navab, M.; Fogelman, A. M. High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection Circulation 2001, 103, 2283-8 10.1161/01.CIR.103.18.2283
97. Precourt, L. P.; Amre, D.; Denis, M. C.; Lavoie, J. C.; Delvin, E.; Seidman, E.; Levy, E. The three-gene paraoxonase family: physiologic roles, actions and regulation Atherosclerosis 2011, 214, 20-36 10.1016/j.atherosclerosis.2010.08.076
98. Mackness, B.; Quarck, R.; Verreth, W.; Mackness, M.; Holvoet, P. Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome Arterioscler., Thromb., Vasc. Biol. 2006, 26, 1545-50 10.1161/01.ATV.0000222924.62641.aa
99. Lusis, A. J.; Shih, D. M.; Gu, L.; Xia, Y.-R.; Navab, M.; Li, W.-F.; Hama, S.; Castellani, L. W.; Furlong, C. E.; Costa, L. G.; Fogelman, A. M. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis Nature 1998, 394, 284-287 10.1038/28406
100. Shih, D. M.; Xia, Y. R.; Wang, X. P.; Miller, E.; Castellani, L. W.; Subbanagounder, G.; Cheroutre, H.; Faull, K. F.; Berliner, J. A.; Witztum, J. L.; Lusis, A. J. Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis J. Biol. Chem. 2000, 275, 17527-35 10.1074/jbc.M910376199
101. Van Lenten, B. J.; Hama, S. Y.; de Beer, F. C.; Stafforini, D. M.; McIntyre, T. M.; Prescott, S. M.; La Du, B. N.; Fogelman, A. M.; Navab, M. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures J. Clin. Invest. 1995, 96, 2758-67 10.1172/JCI118345